TITLE

Endocrinology & metabolism

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS18
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Modulation of BCL-2 proto-oncogene expression by androgens in human breast cancer cells,' by J. Lapointe, A. Fournier and C. Labrie from the Laval University. BCL-2 as an oncoprotein.
ACCESSION #
9708235893

 

Related Articles

  • Caspase 8: The killer you can't live without. Juin, Philippe; Evan, Gerard // Nature Medicine;May2000, Vol. 6 Issue 5, p498 

    Reports that the proto-oncogene MYCN, a regulator of cell proliferation and cell death, is amplified in aggressive neuroblastomas, whereas expression of the apoptotic effector caspase 8 is suppressed. Membership of caspase to a family of cysteine aspartyl proteases that are activated in...

  • Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle. Helbing, Caren C; Wellington, Cheryl L; Gogela-Spehar, Markéta; Cheng, Ting; Pinchbeck, Geoffrey G; Johnston, Randal N // Oncogene;9/24/98, Vol. 17 Issue 12, p1491 

    When exposed to diverse growth conditions in vitro, cells can respond by entering states of proliferation, quiescence, differentiation or apoptosis. While the choices among these states can be influenced by proto-oncogene expression, how these disparate outcomes are achieved remains poorly...

  • Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Groysman, Maya; Nagano, Makoto; Shaanan, Boaz; Katzav, Shulamit // Oncogene;9/24/98, Vol. 17 Issue 12, p1597 

    The vav proto-oncogene encodes a protein with multiple modulae domains that enable it to function as a mediator, linking tyrosine signaling to downstream events in hematopoietic cells. Circumstantial evidence suggests that protein-protein interactions exerted by two of these domains, the Src...

  • Role of c-myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. Yuan Kang; Cortina, Robert // JNCI: Journal of the National Cancer Institute;3/6/96, Vol. 88 Issue 5, p279 

    Examines the role of c-myc proto-oncogene in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. Efficacy of antiestrogen tamoxifen (TAM) for treating breast cancer; Measurement of growth inhibition and apoptosis; Cancer cells' growth response to TAM and c-myc antisense...

  • Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive ... Nistico, Paola; Mottolese, Marcella // JNCI: Journal of the National Cancer Institute;02/19/97, Vol. 89 Issue 4, p319 

    Studies the low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-a2-positive breast cancer patients. Major histocompatibility complex class I molecules as antigens; Encoding of a transmembrane glycoprotein by ErbB-2; Assessment of the estrogen receptor and...

  • Breast cancer and a proto-oncogene. Barnes, Diana M. // BMJ: British Medical Journal (International Edition);10/28/89, Vol. 299 Issue 6707, p1061 

    Reports the significance of proto-oncogene in managing patients with breast cancer in Great Britain. Determination of the proportion of patients with c-erbB-2 protein amplification through DNA analysis or immunohistochemistry; Relationship between c-erbB-2 and poor prognosis; Differentiation of...

  • The role of Herceptin in early breast cancer. Subramanian, Ashok; Mokbel, Kefah // International Seminars in Surgical Oncology;2008, Vol. 5, Special section p1 

    Herceptin is widely regarded as the most important development in the treatment of breast cancer since Tamoxifen and the development of the multidisciplinary team (MDT). It is particularly exciting from an oncological polint of view as it represents success in the emerging field of specific...

  • Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Shulewitz, M.; Soloviev, I.; Wu, T.; Koeppen, H.; Polakis, P.; Sakanaka, C. // Oncogene;7/20/2006, Vol. 25 Issue 31, p4361 

    Mutations in Wnt pathway genes are rare in human breast cancer, yet activation of the pathway is evident from the misolocalization of β-catenin. We searched for relationships in the expression of Wnt pathway genes and found that both secreted frizzled related protein 1 (Sfrp1) and TCF-4...

  • Studies of RET gene expression and acetylcholinesterase activity in a series of sporadic Hirschsprung's disease. Cocelho, Maria Cecília M.; Tannuri, Uenis; Benditt, Israel; Santos, Maria Merces; Coelho, Maria Cecília M // Pediatric Surgery International;Sep2008, Vol. 24 Issue 9, p1017 

    The purpose is to present the studies of RET gene expression and acetylcholinesterase activity in 23 patients operated for Hirschsprung's disease (HD). The patients underwent either transanal endorectal pull-through or Duhamell's procedure. Full-thickness intestinal samples from the three...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics